| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,677 |
26,265 |
$3.13M |
| 99442 |
|
7,481 |
6,996 |
$668K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
4,787 |
4,579 |
$638K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,711 |
3,660 |
$490K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,640 |
1,581 |
$199K |
| 90674 |
|
4,330 |
4,328 |
$132K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,377 |
6,252 |
$117K |
| 99441 |
|
2,025 |
1,977 |
$111K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,398 |
1,360 |
$82K |
| H0001 |
Alcohol and/or drug assessment |
6,790 |
6,704 |
$39K |
| 93000 |
|
1,626 |
1,616 |
$27K |
| 99051 |
|
3,048 |
2,748 |
$19K |
| 90661 |
|
361 |
361 |
$13K |
| 90756 |
|
395 |
395 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
8,435 |
8,328 |
$9K |
| 0013A |
|
198 |
198 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
39 |
39 |
$5K |
| 3078F |
|
1,273 |
1,206 |
$3K |
| 83014 |
|
418 |
416 |
$3K |
| 3074F |
|
1,336 |
1,255 |
$3K |
| 0011A |
|
63 |
63 |
$2K |
| 0012A |
|
41 |
41 |
$2K |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
63 |
63 |
$1K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
198 |
196 |
$1K |
| 77080 |
|
25 |
25 |
$985.17 |
| 3075F |
|
398 |
383 |
$875.00 |
| 90746 |
|
12 |
12 |
$821.21 |
| 94010 |
|
25 |
25 |
$798.75 |
| 83013 |
|
12 |
12 |
$727.44 |
| 3044F |
|
1,770 |
1,425 |
$700.00 |
| 3079F |
|
250 |
240 |
$685.00 |
| 3077F |
|
263 |
248 |
$602.50 |
| 0031A |
|
12 |
12 |
$505.44 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
5,391 |
5,346 |
$327.60 |
| 1159F |
|
3,953 |
3,026 |
$240.00 |
| 90686 |
|
12 |
12 |
$225.69 |
| 99406 |
|
14 |
13 |
$185.36 |
| 1160F |
|
3,954 |
3,027 |
$120.00 |
| 3051F |
|
152 |
133 |
$100.00 |
| 90750 |
|
53 |
53 |
$0.53 |
| 91313 |
|
124 |
124 |
$0.45 |
| 91306 |
|
30 |
30 |
$0.04 |
| 3048F |
|
291 |
275 |
$0.03 |
| 91301 |
|
112 |
104 |
$0.02 |
| G9507 |
Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) |
2,296 |
2,040 |
$0.00 |
| 3725F |
|
4,309 |
4,257 |
$0.00 |
| 3016F |
|
4,717 |
4,657 |
$0.00 |
| G9665 |
Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy |
1,703 |
1,563 |
$0.00 |
| G9621 |
Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling |
99 |
97 |
$0.00 |
| 1032F |
|
71 |
70 |
$0.00 |
| 3045F |
|
84 |
73 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
5,715 |
5,647 |
$0.00 |
| 3015F |
|
160 |
153 |
$0.00 |
| 3050F |
|
665 |
628 |
$0.00 |
| G8506 |
Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy |
571 |
457 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
29 |
28 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
3,373 |
3,282 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
5,763 |
5,562 |
$0.00 |
| 3008F |
|
7,212 |
6,951 |
$0.00 |
| 1000F |
|
4,769 |
4,698 |
$0.00 |
| 1036F |
|
3,722 |
3,679 |
$0.00 |
| 3061F |
|
2,020 |
1,649 |
$0.00 |
| 3060F |
|
226 |
184 |
$0.00 |
| 1034F |
|
28 |
27 |
$0.00 |